Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression

Pierre Luc Boulay, Louise Mitchell, Jason Turpin, Julie Émilie Huot-Marchand, Cynthia Lavoie, Virginie Sanguin-Gendreau, Laura Jones, Shreya Mitra, Julie M. Livingstone, Shirley Campbell, Michael Hallett, Gordon B. Mills, Morag Park, Lewis Chodosh, Douglas Strathdee, Jim C. Norman, William J. Muller

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Rab11-FIP1C is a critical negative regulator in ErbB2-mediated mammary tumor progression'. Together they form a unique fingerprint.

Medicine & Life Sciences